CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Controversies in Hepatitis C Therapy CME
Chairperson: Douglas R. LaBrecque, MD; Faculty: Robert G. Gish, MD; Michael W. Fried, MD; Emmet B. Keeffe, MD
Disclosures

Release Date: November 1, 2002; Valid for credit through November 3, 2003

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


Editorial Content produced by Zephyr Medical Enterprises.
This activity is sponsored by the University of Iowa Roy J. and Lucille A. Carver College of Medicine.
This CME activity, "Controversies in Hepatitis C Therapy", is based on transcripts and slides of presentations as delivered by the faculty at the "Controversies in Hepatitis C Therapy: Point/Counterpoint Debates" satellite symposium held during the AASLD Annual Meeting in Boston, Massachusetts on November 3, 2002.

Request a free multimedia CME CD-ROM of this activity.

Contents of This CME Activity
  1. Introduction

  2. HCV - (Virtually) All Patients Should Be Treated
    Douglas R. LaBrecque, MD
    Chronic Hepatitis C: Epidemiology and Economic Burden
    Natural History and Risk Factors of Hepatitis C
    Treatment Strategies for Chronic Hepatitis C: Therapeutic Efficacy and Effect on Disease Progression
    Cost-Effectiveness of Hepatitis C Therapy
    Hepatitis C Therapy: Recommendations and Considerations

  3. HCV - The Case for Selective Treatment
    Robert G. Gish, MD
    Hepatitis C: Natural History and Independent Predictors of Adverse Outcomes
    Therapeutic Approaches to Hepatitis C: Efficacy and Adverse Events
    Chronic Hepatitis C: Treatment Strategies Under Development
    Treatment for Hepatitis C: Indications, Contraindications, and Future Directions

  4. Liver Biopsy - Just Do It
    Michael W. Fried, MD
    Liver Biopsy for Hepatitis C: Historical Perspective, Complications, and Cost-Effectiveness
    Potential Roles of Liver Biopsy in Hepatitis C
    Liver Biopsy in Special Patient Populations
    Liver Biopsy and Hepatitis C: Summary and Conclusions

  5. Liver Biopsy - Just Think About It
    Emmet B. Keeffe, MD
    Liver Biopsy: Indications, Contraindications, and Complications
    Chronic Hepatitis C: Epidemiology and Natural History
    Role of Liver Biopsy in Hepatitis C
    Alternatives to Liver Biopsy for Predicting Advanced Fibrosis in Chronic Hepatitis C Patients
    Rationale for Selective Utilization of Liver Biopsy for Hepatitis C

  6. Abstracts
    HCV - (Virtually) All Patients Should Be Treated
    Douglas R. LaBrecque, MD
    HCV - The Case for Selective Treatment
    Robert G. Gish, MD
    Liver Biopsy - Just Do It
    Michael W. Fried, MD
    Liver Biopsy - Just Think About It
    Emmet B. Keeffe, MD

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, the CME provider, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright 2002 © Zephyr Medical Enterprises, Inc.
Roche
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.